CN Stock MarketDetailed Quotes

300683 Wuhan Hiteck Biological Pharma

Watchlist
  • 20.71
  • -0.76-3.54%
Market Closed Sep 13 15:00 CST
2.71BMarket Cap-20464P/E (TTM)

Wuhan Hiteck Biological Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-0.64%284.62M
-4.87%131.89M
-12.54%602.28M
-19.80%438.43M
-26.03%286.45M
-16.59%138.64M
12.03%688.63M
39.32%546.64M
71.69%387.23M
5.31%166.2M
Operating revenue
-0.64%284.62M
-4.87%131.89M
-12.54%602.28M
-19.80%438.43M
-26.03%286.45M
-16.59%138.64M
12.03%688.63M
39.32%546.64M
71.69%387.23M
5.31%166.2M
Other operating revenue
-46.91%4.78M
----
-1.04%7.8M
----
197.16%9M
----
21.59%7.89M
----
-17.54%3.03M
----
Total operating cost
3.46%341.12M
20.19%185.59M
3.34%714.28M
-4.78%506.04M
-8.91%329.72M
-4.45%154.42M
14.83%691.22M
42.52%531.42M
66.08%361.96M
11.89%161.62M
Operating cost
-6.28%154.34M
1.67%79.25M
-2.77%345.06M
-14.42%244.73M
-19.26%164.68M
-6.43%77.95M
34.02%354.88M
110.45%285.96M
190.40%203.97M
12.40%83.3M
Operating tax surcharges
23.65%3.38M
23.93%1.42M
-2.96%5.47M
-3.49%3.91M
-0.65%2.73M
-4.12%1.15M
58.69%5.64M
43.63%4.05M
17.04%2.75M
18.44%1.19M
Operating expense
-5.13%64.06M
-11.48%27.79M
1.55%128.66M
2.63%99.32M
14.04%67.53M
1.64%31.4M
-13.02%126.71M
-6.06%96.78M
-9.27%59.21M
-7.35%30.89M
Administration expense
28.27%62.11M
114.77%49.44M
20.80%113.33M
7.49%73.08M
8.18%48.42M
15.88%23.02M
-3.58%93.81M
0.95%67.99M
1.94%44.76M
-1.85%19.86M
Financial expense
63.66%-1.73M
92.64%-241.53K
36.51%-7.14M
34.95%-5.75M
25.64%-4.77M
3.32%-3.28M
10.32%-11.25M
3.29%-8.83M
2.64%-6.41M
14.10%-3.4M
-Interest expense (Financial expense)
29.68%1.41M
222.14%1.19M
114.35%2.39M
47.68%1.72M
11.54%1.09M
-28.95%369.05K
124.92%1.12M
259.82%1.16M
506.81%976.19K
--519.4K
-Interest Income (Financial expense)
42.13%-3.53M
57.45%-1.62M
22.29%-9.99M
24.79%-7.79M
18.35%-6.11M
5.69%-3.8M
5.45%-12.86M
-5.76%-10.36M
-6.48%-7.48M
---4.03M
Research and development
15.33%58.97M
15.47%27.94M
6.15%128.9M
6.16%90.74M
-11.37%51.13M
-18.70%24.2M
17.71%121.43M
17.20%85.47M
34.87%57.69M
51.11%29.76M
Credit Impairment Loss
-65.49%722.16K
-40.39%564.6K
74.31%-974.97K
9,122.68%2.16M
253.44%2.09M
122.90%947.22K
-115.97%-3.79M
100.17%23.43K
88.08%-1.36M
41.81%-4.14M
Asset Impairment Loss
-145.44%-1.41M
370.69%17.7M
-81.03%-60.12M
118.76%1.69M
148.90%3.11M
--3.76M
-183.99%-33.21M
-17.79%-8.99M
-28.90%-6.36M
----
Other net revenue
35.29%27.71M
179.60%25.81M
-635.32%-31.08M
276.72%24.53M
1,327.85%20.48M
651.66%9.23M
-149.24%-4.23M
196.46%6.51M
123.24%1.43M
-73.86%1.23M
Fair value change income
-10.43%6.1M
149.25%5.81M
-85.02%1.9M
241.85%11.65M
1,143.19%6.81M
-10.20%2.33M
3,903.39%12.67M
335.88%3.41M
38.08%-653.22K
194.94%2.59M
Invest income
90.13%4.08M
10,050.76%239.11K
42.06%15.69M
-44.36%2.99M
-63.66%2.15M
-98.48%2.36K
-23.00%11.04M
-47.12%5.37M
-29.83%5.91M
-98.24%155.14K
-Including: Investment income associates
----
----
-15.16%-2.77M
----
----
----
-9,453.53%-2.4M
----
----
----
Asset deal income
-210.95%-43.5K
-210.95%-43.5K
-282.04%-358.67K
-828.31%-2.18M
143.06%39.21K
--39.21K
48.12%-93.88K
684.93%299.27K
-85.71%-91.05K
----
Other revenue
190.92%18.26M
-28.26%1.54M
39.69%12.79M
28.58%8.23M
57.06%6.28M
-17.65%2.15M
11.53%9.16M
8.67%6.4M
38.16%4M
20.31%2.61M
Operating profit
-26.34%-28.79M
-325.78%-27.89M
-1,997.07%-143.07M
-298.19%-43.07M
-185.32%-22.78M
-212.60%-6.55M
-131.97%-6.82M
70.47%21.73M
1,762.08%26.71M
-67.84%5.82M
Add:Non operating Income
-70.62%32.95K
-96.16%3.75K
-59.40%172.06K
-43.20%121.85K
-32.71%112.15K
-96.69%97.53K
-28.81%423.83K
-62.53%214.51K
-19.48%166.67K
9,895.44%2.95M
Less:Non operating expense
-64.98%716.34K
54.39%559.25K
537.43%9.09M
697.99%6.22M
265.72%2.05M
59.65%362.23K
-3.65%1.43M
-16.04%779.56K
-17.20%559.31K
37.46%226.89K
Total profit
-19.22%-29.47M
-317.39%-28.45M
-1,842.57%-151.99M
-332.29%-49.17M
-193.94%-24.72M
-179.82%-6.82M
-138.25%-7.82M
70.81%21.17M
2,624.82%26.31M
-52.45%8.54M
Less:Income tax cost
57.73%-5.03M
-114.80%-10.95M
-32,106.33%-23.74M
-453.74%-19.56M
-1,228.50%-11.9M
-228.44%-5.1M
100.78%74.18K
47.02%-3.53M
121.39%1.05M
-140.99%-1.55M
Net profit
FPtoL-24.44M
FPtoL-17.49M
FPtoL-128.24M
SL-29.62M
SL-12.82M
SL-1.72M
SL-7.9M
29.60%24.7M
328.48%25.26M
-28.77%10.09M
Net profit from continuing operation
-90.68%-24.44M
-919.75%-17.49M
-1,523.72%-128.24M
-219.90%-29.62M
-150.74%-12.82M
-117.00%-1.72M
-126.31%-7.9M
29.60%24.7M
328.48%25.26M
-28.77%10.09M
Less:Minority Profit
0.90%-1.67M
-288.92%-946.15K
-221.02%-7.42M
-154.04%-3.18M
-126.45%-1.69M
-110.14%-243.28K
159.73%6.13M
1,289.40%5.88M
583.12%6.39M
761.82%2.4M
Net profit of parent company owners
-104.58%-22.77M
-1,024.00%-16.55M
-761.20%-120.82M
-240.47%-26.44M
-158.96%-11.13M
-119.14%-1.47M
-150.73%-14.03M
1.00%18.82M
161.49%18.87M
-47.07%7.69M
Earning per share
Basic earning per share
-88.89%-0.17
-550.00%-0.13
-745.45%-0.93
-240.00%-0.21
-160.00%-0.09
-133.33%-0.02
-142.31%-0.11
-16.67%0.15
114.29%0.15
-57.14%0.06
Diluted earning per share
-88.89%-0.17
-550.00%-0.13
-745.45%-0.93
-240.00%-0.21
-160.00%-0.09
-133.33%-0.02
-142.31%-0.11
-16.67%0.15
114.29%0.15
-57.14%0.06
Other composite income
Total composite income
-90.68%-24.44M
-919.75%-17.49M
-1,523.72%-128.24M
-219.90%-29.62M
-150.74%-12.82M
-117.00%-1.72M
-126.31%-7.9M
29.60%24.7M
328.48%25.26M
-28.77%10.09M
Total composite income of parent company owners
-104.58%-22.77M
-1,024.00%-16.55M
-761.20%-120.82M
-240.47%-26.44M
-158.96%-11.13M
-119.14%-1.47M
-150.73%-14.03M
1.00%18.82M
161.49%18.87M
-47.07%7.69M
Total composite income of minority owners
0.90%-1.67M
-288.92%-946.15K
-221.02%-7.42M
-154.04%-3.18M
-126.45%-1.69M
-110.14%-243.28K
159.73%6.13M
1,289.40%5.88M
583.12%6.39M
761.82%2.4M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -0.64%284.62M-4.87%131.89M-12.54%602.28M-19.80%438.43M-26.03%286.45M-16.59%138.64M12.03%688.63M39.32%546.64M71.69%387.23M5.31%166.2M
Operating revenue -0.64%284.62M-4.87%131.89M-12.54%602.28M-19.80%438.43M-26.03%286.45M-16.59%138.64M12.03%688.63M39.32%546.64M71.69%387.23M5.31%166.2M
Other operating revenue -46.91%4.78M-----1.04%7.8M----197.16%9M----21.59%7.89M-----17.54%3.03M----
Total operating cost 3.46%341.12M20.19%185.59M3.34%714.28M-4.78%506.04M-8.91%329.72M-4.45%154.42M14.83%691.22M42.52%531.42M66.08%361.96M11.89%161.62M
Operating cost -6.28%154.34M1.67%79.25M-2.77%345.06M-14.42%244.73M-19.26%164.68M-6.43%77.95M34.02%354.88M110.45%285.96M190.40%203.97M12.40%83.3M
Operating tax surcharges 23.65%3.38M23.93%1.42M-2.96%5.47M-3.49%3.91M-0.65%2.73M-4.12%1.15M58.69%5.64M43.63%4.05M17.04%2.75M18.44%1.19M
Operating expense -5.13%64.06M-11.48%27.79M1.55%128.66M2.63%99.32M14.04%67.53M1.64%31.4M-13.02%126.71M-6.06%96.78M-9.27%59.21M-7.35%30.89M
Administration expense 28.27%62.11M114.77%49.44M20.80%113.33M7.49%73.08M8.18%48.42M15.88%23.02M-3.58%93.81M0.95%67.99M1.94%44.76M-1.85%19.86M
Financial expense 63.66%-1.73M92.64%-241.53K36.51%-7.14M34.95%-5.75M25.64%-4.77M3.32%-3.28M10.32%-11.25M3.29%-8.83M2.64%-6.41M14.10%-3.4M
-Interest expense (Financial expense) 29.68%1.41M222.14%1.19M114.35%2.39M47.68%1.72M11.54%1.09M-28.95%369.05K124.92%1.12M259.82%1.16M506.81%976.19K--519.4K
-Interest Income (Financial expense) 42.13%-3.53M57.45%-1.62M22.29%-9.99M24.79%-7.79M18.35%-6.11M5.69%-3.8M5.45%-12.86M-5.76%-10.36M-6.48%-7.48M---4.03M
Research and development 15.33%58.97M15.47%27.94M6.15%128.9M6.16%90.74M-11.37%51.13M-18.70%24.2M17.71%121.43M17.20%85.47M34.87%57.69M51.11%29.76M
Credit Impairment Loss -65.49%722.16K-40.39%564.6K74.31%-974.97K9,122.68%2.16M253.44%2.09M122.90%947.22K-115.97%-3.79M100.17%23.43K88.08%-1.36M41.81%-4.14M
Asset Impairment Loss -145.44%-1.41M370.69%17.7M-81.03%-60.12M118.76%1.69M148.90%3.11M--3.76M-183.99%-33.21M-17.79%-8.99M-28.90%-6.36M----
Other net revenue 35.29%27.71M179.60%25.81M-635.32%-31.08M276.72%24.53M1,327.85%20.48M651.66%9.23M-149.24%-4.23M196.46%6.51M123.24%1.43M-73.86%1.23M
Fair value change income -10.43%6.1M149.25%5.81M-85.02%1.9M241.85%11.65M1,143.19%6.81M-10.20%2.33M3,903.39%12.67M335.88%3.41M38.08%-653.22K194.94%2.59M
Invest income 90.13%4.08M10,050.76%239.11K42.06%15.69M-44.36%2.99M-63.66%2.15M-98.48%2.36K-23.00%11.04M-47.12%5.37M-29.83%5.91M-98.24%155.14K
-Including: Investment income associates ---------15.16%-2.77M-------------9,453.53%-2.4M------------
Asset deal income -210.95%-43.5K-210.95%-43.5K-282.04%-358.67K-828.31%-2.18M143.06%39.21K--39.21K48.12%-93.88K684.93%299.27K-85.71%-91.05K----
Other revenue 190.92%18.26M-28.26%1.54M39.69%12.79M28.58%8.23M57.06%6.28M-17.65%2.15M11.53%9.16M8.67%6.4M38.16%4M20.31%2.61M
Operating profit -26.34%-28.79M-325.78%-27.89M-1,997.07%-143.07M-298.19%-43.07M-185.32%-22.78M-212.60%-6.55M-131.97%-6.82M70.47%21.73M1,762.08%26.71M-67.84%5.82M
Add:Non operating Income -70.62%32.95K-96.16%3.75K-59.40%172.06K-43.20%121.85K-32.71%112.15K-96.69%97.53K-28.81%423.83K-62.53%214.51K-19.48%166.67K9,895.44%2.95M
Less:Non operating expense -64.98%716.34K54.39%559.25K537.43%9.09M697.99%6.22M265.72%2.05M59.65%362.23K-3.65%1.43M-16.04%779.56K-17.20%559.31K37.46%226.89K
Total profit -19.22%-29.47M-317.39%-28.45M-1,842.57%-151.99M-332.29%-49.17M-193.94%-24.72M-179.82%-6.82M-138.25%-7.82M70.81%21.17M2,624.82%26.31M-52.45%8.54M
Less:Income tax cost 57.73%-5.03M-114.80%-10.95M-32,106.33%-23.74M-453.74%-19.56M-1,228.50%-11.9M-228.44%-5.1M100.78%74.18K47.02%-3.53M121.39%1.05M-140.99%-1.55M
Net profit FPtoL-24.44MFPtoL-17.49MFPtoL-128.24MSL-29.62MSL-12.82MSL-1.72MSL-7.9M29.60%24.7M328.48%25.26M-28.77%10.09M
Net profit from continuing operation -90.68%-24.44M-919.75%-17.49M-1,523.72%-128.24M-219.90%-29.62M-150.74%-12.82M-117.00%-1.72M-126.31%-7.9M29.60%24.7M328.48%25.26M-28.77%10.09M
Less:Minority Profit 0.90%-1.67M-288.92%-946.15K-221.02%-7.42M-154.04%-3.18M-126.45%-1.69M-110.14%-243.28K159.73%6.13M1,289.40%5.88M583.12%6.39M761.82%2.4M
Net profit of parent company owners -104.58%-22.77M-1,024.00%-16.55M-761.20%-120.82M-240.47%-26.44M-158.96%-11.13M-119.14%-1.47M-150.73%-14.03M1.00%18.82M161.49%18.87M-47.07%7.69M
Earning per share
Basic earning per share -88.89%-0.17-550.00%-0.13-745.45%-0.93-240.00%-0.21-160.00%-0.09-133.33%-0.02-142.31%-0.11-16.67%0.15114.29%0.15-57.14%0.06
Diluted earning per share -88.89%-0.17-550.00%-0.13-745.45%-0.93-240.00%-0.21-160.00%-0.09-133.33%-0.02-142.31%-0.11-16.67%0.15114.29%0.15-57.14%0.06
Other composite income
Total composite income -90.68%-24.44M-919.75%-17.49M-1,523.72%-128.24M-219.90%-29.62M-150.74%-12.82M-117.00%-1.72M-126.31%-7.9M29.60%24.7M328.48%25.26M-28.77%10.09M
Total composite income of parent company owners -104.58%-22.77M-1,024.00%-16.55M-761.20%-120.82M-240.47%-26.44M-158.96%-11.13M-119.14%-1.47M-150.73%-14.03M1.00%18.82M161.49%18.87M-47.07%7.69M
Total composite income of minority owners 0.90%-1.67M-288.92%-946.15K-221.02%-7.42M-154.04%-3.18M-126.45%-1.69M-110.14%-243.28K159.73%6.13M1,289.40%5.88M583.12%6.39M761.82%2.4M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data